According to an International Business Times article dated today, state media reported on Monday that China has launched a probe into infant deaths connected to Hepatitis B vaccines in the country, following the seventh death in Shenzhen last week when an infant died about 70 minutes after he was vaccinated with the Hepatitis B vaccine.
At least four deaths from Hepatitis B vaccinations have been reported since November from the southern province of Guangdong, 930 miles from Shanghai, the largest city by population in the world. Two deaths were reported in Hunan Province in central China, and one death was reported in southwestern Sichuan province, according to authorities.
The majority of the infant deaths occurred within an hour to two days from the time of vaccination.
China’s health, food and drug authorities and the National Health and Family Planning Commission have ordered hospitals to stop using the Hepatitis B vaccines which allegedly caused the deaths. They were manufactured by Shenzhen-based Biokangtai. China Daily reported that the health ministry is investigating the deaths and the company’s products. Biokangtai sells 10 million vaccines a year in China and has a 60 percent share of the market, according to The Time Weekly.
Don't miss another article! Subscribe to email alerts here.